Patent · US Active

Method and composition for administering an NMDA receptor antagonist to a subject

US8426472B2 · kind B2 · utility

20Cited by

84References

10Claims

0Family size

Assignee

Adamas Pharmaceuticals, Inc. · US

Inventors

Gregory T. Went · Mill Valley, US
Timothy J. Fultz · Martinez, US
Seth Porter · Redwood City, US
Laurence R. Meyerson · Las Vegas, US
Timothy S. Burkoth · Lake Bluff, US

Key dates

Filing date	Oct 28, 2011
Grant date	Apr 23, 2013
Priority date	—
Expiry date	Oct 28, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P25/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides methods and compositions for administering an NMDA receptor antagonist (e.g., memantine) to a subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.